欢迎访问广州呼吸健康研究院!
奉献、开拓、实干、合群
2024-07-01 本站原创 1
Aims and Scope
The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624) is an international, peer-reviewed, open-access journal, which was founded in Dec 2009. JTD is indexed by Science Citation Index Expanded (SCIE), PubMed/PubMed Central and Scopus. It is published quarterly (Dec 2009- Dec 2011), bimonthly (Jan 2012 - Dec 2013), monthly (Jan. 2014-). JTD received its impact factor of 2.895 for the year 2020. JTD publishes manuscripts that describe new findings and provide current, practical information on the diagnosis and treatment of conditions related to thoracic disease. All the submission and reviewing are conducted electronically so that rapid review is assured.
Information for Authors
JTD is a member of Committee on Publication Ethics (COPE) and it follows the Committee on Publication Ethics (COPE)'s guidelines and the ICMJE recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journal.
Manuscripts submitted must be the original work of the author(s) and must not be published previously or under consideration for publication elsewhere.
Submission Turnaround Time
In-house review: 1-3 weeks
External peer review: 1-3 months
Publication Ahead of Print: within 1 month after being accepted
Formal publication: within 1-3 months after being accepted. Original Articles are listed as priority.
JTD is the official publication of:
China State Key Laboratory of Respiratory Disease
Guangzhou Institute of Respiratory Health (GIRH)
The First Affiliated Hospital of Guangzhou Medical University
The Society of Translational Medicine (STM)
JTD is endorsed by:
International COPD Coalition (ICC)
China Asthma Alliance (CAA)
Global Alliance against Chronic Respiratory Diseases (GARD)
Publisher Information
JTD is published by AME Publishing Company.
Address: Flat/RM C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong, China.